Epileptic encephalopathy represents one of the most challenging groups of childhood brain disorders, where the goal of treatment extends far beyond simply stopping seizures—it focuses on protecting and restoring brain function to help children develop and learn as normally as possible.

How Treatment Focuses on Protecting Young Brains

When doctors approach the treatment of epileptic encephalopathy, they are working against time and a complex enemy. Unlike many forms of epilepsy where the main concern is preventing seizures, this condition demands a broader strategy. The electrical storms happening in the brain—both during actual seizures and between them—actively damage the developing nervous system, leading to loss of skills the child has already learned or preventing new abilities from forming^[1].

The treatment plan for epileptic encephalopathy depends heavily on several factors. The child’s age plays a crucial role, as does the specific syndrome they have been diagnosed with. Some children begin experiencing problems in the first weeks of life, while others may develop symptoms later in childhood. The severity of seizures, the pattern seen on brain wave tests, and how the child’s development has been affected all influence which treatments doctors will try first^[2].

Modern medical practice recognizes that there are established treatments approved by major epilepsy organizations worldwide, including medications that have been used for years. However, researchers continue to explore new therapeutic approaches through clinical trials, seeking better ways to control the electrical abnormalities and protect cognitive function. The International League Against Epilepsy has provided guidelines that help doctors navigate treatment decisions, though many aspects of managing these conditions remain challenging^[3].

Standard Medical Approaches to Treatment

The treatment of epileptic encephalopathy typically begins with antiepileptic drugs, though the choice of medication differs from what might be used in other types of epilepsy. Doctors tend to favor medications known as “spike suppressors”—drugs that are particularly effective at reducing the abnormal electrical discharges seen on electroencephalogram (EEG) tests. These medications include valproic acid, benzodiazepines such as diazepam or clobazam, ethosuximide, levetiracetam, and lamotrigine^[7].

The way these medications work involves calming overexcited nerve cells in the brain. Valproic acid, for instance, increases the levels of a chemical messenger called GABA that helps quiet brain activity. Benzodiazepines enhance the effect of GABA, creating a calming effect on the nervous system. However, doctors must use these drugs carefully because in some cases, the wrong antiepileptic medication can actually make seizures worse or cause further cognitive problems^[9].

When standard antiepileptic drugs fail to control seizures or improve the EEG patterns, doctors often turn to hormonal therapies. The most commonly used hormonal treatment is adrenocorticotropic hormone (ACTH), a substance that stimulates the adrenal glands to produce cortisol. ACTH is particularly important in treating infantile spasms, also known as West syndrome, one of the most common forms of epileptic encephalopathy in babies. Doctors may also use corticosteroids like prednisone or prednisolone, which work similarly to reduce inflammation in the brain and suppress abnormal electrical activity^[7].

The duration of treatment with antiepileptic drugs and hormonal therapies varies considerably. Some children may need to stay on medications for months or years, while others might eventually be weaned off if their condition improves. ACTH treatment typically lasts for several weeks, with the dose gradually reduced over time. The decision about how long to continue treatment depends on how well the seizures are controlled, whether the EEG pattern improves, and whether the child’s development begins to progress again^[9].

Immune therapies represent another important treatment strategy. These include intravenous immunoglobulin (IVIG), which provides antibodies that may help calm an overactive immune response affecting the brain. Some doctors also use plasmapheresis, a procedure that filters the blood to remove harmful antibodies. These approaches are based on the understanding that in some cases of epileptic encephalopathy, the immune system may be attacking the brain tissue or contributing to inflammation that worsens seizures and developmental problems^[2].

The ketogenic diet has become an established treatment option for children whose seizures do not respond to medications. This special diet is very high in fats and very low in carbohydrates, which forces the body to burn fat for energy instead of sugar. This metabolic change produces substances called ketones that seem to have an anti-seizure effect. The diet must be carefully calculated and monitored by a dietitian and medical team, as it requires precise proportions of nutrients. Many families find it challenging to maintain, but for some children with epileptic encephalopathy, it can significantly reduce seizures when medications have failed^[7].

Side effects from standard treatments can be significant and must be carefully weighed against potential benefits. Antiepileptic drugs may cause drowsiness, making children sleepy or less alert. Some can affect coordination and balance, making it hard for a child to walk steadily. Memory and thinking problems can occur with certain medications, which is particularly concerning in children already struggling with development. Valproic acid can cause weight gain and, in rare cases, liver problems. Benzodiazepines may lead to increased drooling and behavioral changes^[9].

ACTH and corticosteroids come with their own set of potential side effects. These hormonal treatments can cause irritability and mood changes, difficulty sleeping, increased appetite and weight gain, high blood pressure, and a temporary increase in blood sugar levels. The immune system may become temporarily weakened, making infections more likely. Because of these risks, children receiving hormonal therapy need close monitoring with regular check-ups and blood tests^[7].

For children who have a specific structural problem in the brain that can be identified on imaging tests—such as a scar, malformation, or small tumor—epilepsy surgery may be an option. The surgical approach involves removing or disconnecting the abnormal brain tissue that is generating the seizures. This is not possible for all children with epileptic encephalopathy, but when a clear focal point can be found and it is located in a part of the brain that can be safely operated on, surgery can sometimes provide dramatic improvement. The decision to proceed with surgery requires extensive evaluation including specialized brain imaging and EEG monitoring^[7].

Other surgical approaches include vagus nerve stimulation, where a device is implanted under the skin in the chest with a wire connected to the vagus nerve in the neck. The device sends regular electrical pulses to the brain that can help reduce seizure frequency. This is typically considered when medications have not been successful but surgery to remove brain tissue is not an option. The device does not cure epilepsy but can provide additional seizure control when combined with medications^[9].

Promising Therapies Being Tested in Clinical Trials

Clinical research continues to search for better treatments for epileptic encephalopathy, with studies happening in specialized epilepsy centers around the world. These trials are testing new medications, different combinations of existing drugs, and entirely novel approaches to treating these devastating conditions. Understanding the phase of a clinical trial helps explain what researchers are trying to learn at each stage^[7].

Phase I trials focus primarily on safety. Researchers carefully study a new drug or treatment in a small number of patients to determine whether it is safe to use, what dose should be given, and what side effects might occur. These early studies are crucial for understanding how the treatment behaves in the human body and whether it is worth pursuing further research.

Phase II trials examine whether a treatment actually works. These studies enroll more patients and focus on whether the treatment improves seizure control, normalizes EEG patterns, or helps preserve or restore developmental skills. Researchers carefully measure outcomes and continue to monitor for side effects. If a treatment shows promise in Phase II, it can move forward to larger studies^[7].

Phase III trials are large comparison studies that test a promising new treatment against current standard treatments or placebo. These studies provide the strongest evidence about whether a new therapy should become part of routine medical practice. Phase III trials for epileptic encephalopathy often involve multiple medical centers across different countries to enroll enough patients with these relatively rare conditions.

Several innovative treatment approaches are currently being explored in clinical trials. Research into gene therapy is investigating whether correcting genetic defects that cause certain forms of epileptic encephalopathy might stop or reverse the condition. Since many cases of epileptic encephalopathy are now known to result from mutations in specific genes—such as ARX, CDKL5, SLC25A22, and STXBP1—researchers are exploring whether delivering correct copies of these genes or silencing the abnormal ones could provide benefit^[6].

New immunotherapy approaches are being tested based on growing evidence that immune system dysfunction plays a role in some epileptic encephalopathies. Clinical trials are examining different antibody treatments and immune-modulating drugs that might calm inflammation in the brain more effectively than current therapies. Some of these approaches target specific immune chemicals called cytokines that promote inflammation, while others aim to reset the immune system’s response^[12].

Enzyme inhibitors represent another area of active research. Some epileptic encephalopathies result from metabolic problems where certain enzymes do not work properly. Researchers are testing compounds that might help bypass or correct these enzymatic defects. For example, in cases where epilepsy results from problems with how the brain uses vitamin B6, trials have examined different forms of this vitamin as treatment^[12].

Novel antiepileptic drugs with different mechanisms of action are continuously being evaluated. These new medications aim to target brain pathways that existing drugs do not effectively reach. Some work by blocking specific channels that allow electrical signals to pass between nerve cells, while others enhance natural calming systems in the brain through previously unexplored mechanisms. Clinical trials test these drugs both alone and in combination with established treatments^[12].

Research is also examining whether adjusting the timing, dose, or combination of existing treatments might improve outcomes. For instance, some trials are studying whether starting ACTH earlier in the course of infantile spasms, or using higher doses for shorter periods, might provide better results. Other studies examine whether combining hormonal therapy with specific antiepileptic drugs produces better outcomes than either treatment alone^[7].

Studies on epileptic encephalopathy occur at major medical centers with specialized expertise in treating these conditions. In the United States, institutions like NYU Langone, Montefiore Medical Center, and centers affiliated with the Epilepsy Foundation conduct trials. Research also takes place at centers across Europe and in other parts of the world. Eligibility for clinical trials typically requires a confirmed diagnosis of a specific epileptic encephalopathy syndrome, documented failure of standard treatments, and meeting age criteria that vary by study^[10].

While clinical trials offer hope for new treatments, families should understand that participation involves both potential benefits and risks. The experimental nature of these treatments means outcomes are uncertain, and unknown side effects may occur. However, for children who have not responded to standard therapies, clinical trials may provide access to potentially helpful treatments that are not otherwise available. Families considering trial participation should thoroughly discuss the specific study with their child’s doctors and the research team^[12].

Most common treatment methods

• Antiepileptic Medications
  • Valproic acid increases GABA neurotransmitter to calm brain electrical activity
  • Benzodiazepines (diazepam, clobazam) enhance natural calming systems in the nervous system
  • Levetiracetam and lamotrigine are favored as spike suppressors that reduce abnormal EEG discharges
  • Must be selected carefully as some drugs can worsen seizures or cognitive function
• Hormonal Therapy
  • Adrenocorticotropic hormone (ACTH) stimulates adrenal glands and is especially important for infantile spasms
  • Corticosteroids (prednisone, prednisolone) reduce brain inflammation and suppress abnormal electrical activity
  • Treatment typically lasts several weeks with gradual dose reduction
  • Requires close monitoring due to side effects including irritability, weight gain, and increased infection risk
• Immune Therapy
  • Intravenous immunoglobulin (IVIG) provides antibodies to calm overactive immune response
  • Plasmapheresis filters blood to remove harmful antibodies
  • Based on understanding that immune system may contribute to brain inflammation
• Ketogenic Diet
  • High-fat, very low-carbohydrate diet forces body to burn fat producing ketones
  • Ketones appear to have anti-seizure effects
  • Requires precise calculation and monitoring by dietitian and medical team
  • Can significantly reduce seizures when medications fail
• Surgical Interventions
  • Brain surgery removes or disconnects abnormal tissue causing seizures when focal point identified
  • Vagus nerve stimulation uses implanted device sending electrical pulses to reduce seizure frequency
  • Surgery considered when medications unsuccessful and safe surgical target exists
  • Requires extensive evaluation including specialized imaging and EEG monitoring